Ovarian cancer family and prophylactic choices.

Por Eccles, D M, Houlston, R S
Publicado em 1992

High-grade ER-negative tumour breast cancers are characteristic of both very young onset cases and patients with hereditary breast cancer

Por Eccles, D, Gerty, S, Simmonds, P
Publicado em 2006

Guidelines for a genetic risk based approach to advising women with a family history of breast cancer

Por Eccles, D, Evans, D, Mackay, J
Publicado em 2000

BRCA1 mutation and neuronal migration defect: implications for chemoprevention

Por Eccles, D, Bunyan, D, Barker, S, Castle, B
Publicado em 2005

BRCA1 mutation and neuronal migration defect: implications for chemoprevention

Por Eccles, D, Bunyan, D, Barker, S, Castle, B
Publicado em 2005

Neuronal migration defect in a BRCA1 gene carrier: possible focal nullisomy?

Por Eccles, D, Barker, S, Pilz, D, Kennedy, C
Publicado em 2003

A novel 3' mutation in the APC gene in a family presenting with a desmoid tumour

Por Eccles, D., Harvey, J., Bateman, A., Ross, F.
Publicado em 2001

Small cell carcinoma of the oesophagus: report of three cases and review of published cases.

Por Eccles, D M, Allan, S G, Sang, C T, Cornbleet, M A
Publicado em 1989

TP53 intron 6 polymorphism and the risk of ovarian and breast cancer.

Por Mavridou, D., Gornall, R., Campbell, I. G., Eccles, D. M.
Publicado em 1998

BRCA1 polymorphisms.

Por Campbell, I. G., Schroff, R., Englefield, P., Eccles, D. M.
Publicado em 1997

No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer.

Por Manolitsas, T. P., Englefield, P., Eccles, D. M., Campbell, I. G.
Publicado em 1997

Genetic epidemiology of early onset breast cancer.

Por Eccles, D, Marlow, A, Royle, G, Collins, A, Morton, N E
Publicado em 1994

BRCA1 mutations in southern England.

Por Eccles, D. M., Englefield, P., Soulby, M. A., Campbell, I. G.
Publicado em 1998

Understanding of BRCA VUS genetic results by breast cancer specialists

Por Eccles, B. K., Copson, E., Maishman, T., Abraham, J. E., Eccles, D. M.
Publicado no BMC Cancer (2015)

Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.

Por Naylor, M S, Stamp, G W, Foulkes, W D, Eccles, D, Balkwill, F R
Publicado em 1993

Genotype-phenotype correlations of new causative APC gene mutations in patients with familial adenomatous polyposis.

Por Bunyan, D J, Shea-Simonds, J, Reck, A C, Finnis, D, Eccles, D M
Publicado em 1995

Management of Hereditary Breast Cancer

Por Eccles, D. M., Simmonds, P., Goddards, J., Coultas, M., Lalloo, F., Evans, G., Haites, N.
Publicado em 1999

Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.

Por Eccles, D. M., Brett, L., Lessells, A., Gruber, L., Lane, D., Steel, C. M., Leonard, R. C.
Publicado em 1992

Minisatellite instability is found in colorectal tumours with mismatch repair deficiency

Por Coleman, M G, Gough, A C, Bunyan, D J, Braham, D, Eccles, D M, Primrose, J N
Publicado em 2001

An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis

Por Maishman, T, Copson, E, Stanton, L, Gerty, S, Dicks, E, Durcan, L, Wishart, G C, Pharoah, P, Eccles, D
Publicado no Br J Cancer (2015)